У нас вы можете посмотреть бесплатно GLP-1 for Cardiovascular Protection: What the Data Really Says или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Many people still think GLP-1 medications are “only for weight loss.” But the conversation around GLP-1 for cardiovascular protection is changing fast, especially for patients who meet specific criteria and have metabolic risk factors like diabetes or obesity-related conditions. This highlight breaks down what the evidence suggests about reduced cardiovascular events in certain populations, why eligibility matters, and why the benefits can’t be simplified to “weight loss alone.” It also explores real-world barriers, like insurance rules and clinical awareness, that can shape what patients are offered in standard settings. You’ll also hear a nuanced discussion about dosing concepts such as tolerance over time (tachyphylaxis), why “microdosing” is a separate conversation from FDA-labeled use, and why personalization matters when the goal is long-term metabolic and cardiovascular risk reduction. If you’re trying to understand GLP-1 for cardiovascular protection in a clear, practical way, without hype, this segment will help you ask better questions and think more strategically about prevention, labs, and risk. Click the link below to watch the full episode. 👉 • Hormone Pellet Therapy for Women: Benefits... Chapters: 00:00 - GLP-1: “Not just weight loss” and the heart-health question 00:44 - Cardiovascular approval: what “criteria” really means 01:20 - Why many doctors don’t discuss CV indications 01:55 - What studies show in diabetes and higher-risk groups 02:05 - Microdosing discussion: two practical approaches 02:18 - Tachyphylaxis: why tolerance can change dosing needs 03:06 - Cycling vs continuous use: what clinicians are trying 03:48 - Side effects vs dose: why “lower and spaced” comes up 04:24 - Limits of evidence: why microdosing studies are scarce 05:00 - Labs + risk stratification: lipids and inflammation markers 05:25 - Using GLP-1 in non-obese patients (clinical reasoning) 06:30 - “Quick win” psychology: motivation and behavior change 08:00 - Tools that may help when appropriate: broader wellness plan 09:10 - Sustainable results: procedures vs lifestyle coaching reality 10:00 - Women’s health dialogue: changing messaging and next steps Visit this link to learn more https://www.alluremedical.com ⬅️ Find your nearest location: ⬇️ 📍Shelby Township, MI: https://share.google/gN1n97MX8RKeBNrrt 📍Livonia, MI: https://maps.app.goo.gl/RyafBZT69HN1v... 📍Clarkston, MI: https://maps.app.goo.gl/LqcEcDyYdrNnU... 📍Ann Arbor, MI: https://maps.app.goo.gl/XWZTLawdHv4ye... 📍Warren, MI: https://maps.app.goo.gl/cfPqYBuu678mA... 📍Southgate, MI: https://maps.app.goo.gl/ktCYa9mmfihKM... 📍Greenville, SC: https://maps.app.goo.gl/zDtENNPdnmfxt... 📍Spartanburg, SC: https://maps.app.goo.gl/jv9NMihuia2YU... 📍West Columbia, SC: https://maps.app.goo.gl/BaWw2Qo5S8oQG... 📍Mt Pleasant, SC: https://maps.app.goo.gl/7zzrp8p6vo47F... 📍Charlotte, NC: https://maps.app.goo.gl/D85XX9rUTXwn9... 📍Cornelius, NC: https://maps.app.goo.gl/zHpyxLnsqkhW2... 📍Raleigh, NC: https://maps.app.goo.gl/Lg9br7GD5PgVS... 📍Greensboro, NC: https://maps.app.goo.gl/sqv8h6AJUHDji... Thank you for watching: GLP-1 for Cardiovascular Protection: More Than Weight Loss Our content is for informational purposes only and should not be treated as medical or health advice. Please consult with your doctor / healthcare provider if you have any questions about your medical condition. #glp1 #glp1medication #weightloss